Andrea Zangrando

Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways

Lüder Hinrich Meyer, Sarah M. Eckhoff, Manon Queudeville et al. · Cancer Cell · 2011 · 90 citations · Full text

Hematological Malignancy, Nod/scid Mice, All Is +11

Gene Expression–Based Classification As an Independent Predictor of Clinical Outcome in Juvenile Myelomonocytic Leukemia

Silvia Bresolin, Marco Zecca, Christian Flotho et al. · Journal of Clinical Oncology · 2010 · 74 citations · Full text

Engineering, Mixed-phenotype Acute Leukemia, Pathology +23

A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients

Marco Agostini, Andrea Zangrando, Chiara Pastrello et al. · Cancer Biology & Therapy · 2015 · 70 citations · Full text

Surgical Oncology, Pathology, Akaike Information Criterion +17

Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks

Silvia Bungaro, Marta Dell’Orto, Andrea Zangrando et al. · Genes Chromosomes and Cancer · 2008 · 63 citations · Full text

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures

Andrea Zangrando, Marta Dell’Orto, Geertruy te Kronnie et al. · BMC Medical Genomics · 2009 · 44 citations · Full text